Business
Behind the FDA's AI Push: A Growing Class of Public Healthcare Innovators
Behind the FDA's AI Push: A Growing Class of Public Healthcare Innovators Canada NewsWi...
About this update from Healwell Ai Inc. Class A
[{"type":"text","content":"\n\n\n\n Behind the FDA's AI Push: A Growing Class of Public Healthcare Innovators\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n\n\n USA\n \n News Group\n \n\n\n\n News Commentary\n \n\n\n\n Issued on behalf of Avant Technologies Inc.\n \n\n\n\n\n\n VANCOUVER, BC\n \n\n ,\n \n\n May 13, 2025\n \n\n /CNW/ --\n \n\n\n\n USA\n \n News Group\n \n\n\n\n News Commentary\n \n – In a clear sign of growing confidence in artificial intelligence (AI) for healthcare, the\n \n U.S. Food and Drug Administration (FDA)\n \n has now\n \n\n fully adopted internal AI use\n \n\n , following the successful trial of a generative AI tool designed to streamline scientific review. The system, which helps\n \n FDA\n \n experts reduce time spent on repetitive tasks, marks a pivotal shift toward automation within regulatory processes. Analysts say this shift further confirms AI's growing role in the future of medicine, with\n \n MarketsandMarkets\n \n projecting the\n \n\n AI healthcare sector\n \n\n to climb at a 38.6% CAGR, reaching over\n \n US$110.61 billion\n \n by 2030. As the\n \n FDA\n \n leans into AI for its own operations, attention is turning to public companies advancing their own healthcare AI platforms—among them\n \n Avant Technologies, Inc.\n \n (OTCQB: AVAI),\n \n RadNet, Inc.\n \n (NASDAQ: RDNT),\n \n iCad, Inc.\n \n (NASDAQ: ICAD),\n \n Microsoft Corporation\n \n (NASDAQ: MSFT), and\n \n HEALWELL AI Inc.\n \n (TSX: AIDX) (OTCQX: HWAIF).\n \n\n\n\n\n\n\n\n\n Major funding continues to pour into the AI healthcare sector, highlighted by\n \n Persivia's\n \n recent\n \n\n\n $107 million\n \n raise\n \n\n to scale its AI-powered platform. Looking ahead, analysts project that by 2035, artificial intelligence could inject an\n \n\n additional\n \n $461 billion\n \n\n\n into a global healthcare system already set to exceed\n \n $2.26 trillion\n \n .\n \n\n\n Avant Technologies, Inc.\n \n (OTCQB: AVAI) is deepening its footprint in AI-driven healthcare through a proposed acquisition of its joint venture partner\n \n Ainnova Tech\n \n ....